Healthy aging

Buck Institute expert on the challenges of aging research

Buck Institute expert on the challenges of aging research

By Stephen Daniells

There is huge excitement from the nutrition industry and consumers around healthspan and longevity, but clinical trials to study aging can be challenging because of the number of participants and durations needed. And don’t forget the troublesome...

Special edition: Women’s health

Special edition: Women’s health

Women’s health focused news updates include the latest research, NPD, market insights, regulatory restrictions and untapped opportunities.

Entrenching ergothioneine as longevity vitamin

Entrenching ergothioneine as longevity vitamin

By Asia Sherman

Emerging research continues to position ergothioneine—which up until recently was a fairly obscure dietary compound—as a longevity vitamin, one that is not required for short-term survival but perhaps essential for long-term health.

NHANES data supports post-Covid boom in supplement use

NHANES data supports post-Covid boom in supplement use

By Ben Hargreaves

A new study finds that dietary supplement use has increased substantially over the last decade in the United States, with a similar rise seen in individuals taking four or more supplements concurrently.

Meta-analysis supports vitamin K2’s bone health benefits

Meta-analysis supports vitamin K2’s bone health benefits

By Stephen Daniells

Data from over 2,500 postmenopausal women with osteoporosis revealed that vitamin K2 supplementation can improve biomarkers of bone turnover, supporting the vitamin’s benefits for bone metabolism and skeletal health.

NutraWomen Wednesday: May Yamada-Lifton, CEO, Maypro

NutraWomen Wednesday: May Yamada-Lifton, CEO, Maypro

By Danielle Masterson

May Yamada-Lifton, CEO of Maypro, attributes her leadership approach to an upbringing that blended American independence with Japanese values of loyalty and long-term thinking.

NAD+ market analysis: From hype to reality check

Guest column

NAD+ market analysis: From hype to reality check

By Afif Ghannoum, CEO, CPG Radar

The NAD+ supplement market is experiencing a dramatic transformation that reveals a fundamental shift in consumer behavior. While scientific curiosity about NAD+ has surged 133% since early 2024, actual purchase intent has collapsed by nearly half.